HEADER LIGASE 23-APR-05 1X2H TITLE CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI TITLE 2 COMPLEXED WITH LIPOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIPOATE-PROTEIN LIGASE A; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 6.3.2.-; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: B834(DE3)PLYSS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-3A KEYWDS LIPOATE-PROTEIN LIGASE, LIPOIC ACID, PROTEIN ACYLATION, POST- KEYWDS 2 TRANSLATIONAL MODIFICATION, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR K.FUJIWARA,S.TOMA,K.OKAMURA-IKEDA,Y.MOTOKAWA,A.NAKAGAWA,H.TANIGUCHI REVDAT 5 03-APR-24 1X2H 1 REMARK SEQADV LINK REVDAT 4 11-OCT-17 1X2H 1 REMARK REVDAT 3 24-FEB-09 1X2H 1 VERSN REVDAT 2 04-OCT-05 1X2H 1 JRNL REVDAT 1 02-AUG-05 1X2H 0 JRNL AUTH K.FUJIWARA,S.TOMA,K.OKAMURA-IKEDA,Y.MOTOKAWA,A.NAKAGAWA, JRNL AUTH 2 H.TANIGUCHI JRNL TITL CRYSTAL STRUCTURE OF LIPOATE-PROTEIN LIGASE A FROM JRNL TITL 2 ESCHERICHIA COLI: DETERMINATION OF THE LIPOIC ACID-BINDING JRNL TITL 3 SITE JRNL REF J.BIOL.CHEM. V. 280 33645 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 16043486 JRNL DOI 10.1074/JBC.M505010200 REMARK 2 REMARK 2 RESOLUTION. 2.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 27666 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1533 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.91 REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 REFLECTION IN BIN (WORKING SET) : 1955 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7891 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.59000 REMARK 3 B22 (A**2) : -0.05000 REMARK 3 B33 (A**2) : -0.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.435 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.303 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.864 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.859 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8084 ; 0.020 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10951 ; 1.976 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 992 ; 8.038 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 406 ;35.855 ;23.596 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1344 ;21.670 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 73 ;19.997 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1196 ; 0.119 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6240 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3992 ; 0.254 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 5509 ; 0.329 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 329 ; 0.169 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 76 ; 0.195 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.169 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5048 ; 0.845 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7946 ; 1.467 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3394 ; 2.238 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3005 ; 3.692 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1X2H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-APR-05. REMARK 100 THE DEPOSITION ID IS D_1000024295. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL44XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92154 REMARK 200 MONOCHROMATOR : SI 111 DOUBLE CRYSTAL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER DIP-6040 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29247 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 200.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: DIFFERENCE FOURIER REMARK 200 STARTING MODEL: LIPOATE PROTEIN LIGASE A FROM E. COLI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ETHYLENE GLYCOL, GLYCEROL, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 144.80000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 144.80000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.80000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.80000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 144.80000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.80000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 144.80000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.80000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 176 REMARK 465 ILE A 177 REMARK 465 THR A 178 REMARK 465 SER A 179 REMARK 465 VAL A 180 REMARK 465 ARG A 181 REMARK 465 SER A 182 REMARK 465 GLY B 176 REMARK 465 ILE B 177 REMARK 465 THR B 178 REMARK 465 SER B 179 REMARK 465 VAL B 180 REMARK 465 ARG B 181 REMARK 465 SER B 182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 2 NH1 ARG A 32 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 197 CG GLU A 197 CD 0.094 REMARK 500 GLU B 197 CG GLU B 197 CD 0.096 REMARK 500 CYS C 55 CB CYS C 55 SG -0.107 REMARK 500 CYS C 311 CB CYS C 311 SG -0.097 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 145 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 LEU B 290 CA - CB - CG ANGL. DEV. = -14.3 DEGREES REMARK 500 ARG B 326 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG C 66 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 29 28.35 -69.52 REMARK 500 ALA A 40 -172.17 -65.26 REMARK 500 ASN A 121 -78.47 -102.13 REMARK 500 SER A 135 119.31 -168.35 REMARK 500 ASN A 155 59.16 -150.15 REMARK 500 LEU A 158 -71.71 -60.29 REMARK 500 SER A 159 -19.04 -47.24 REMARK 500 PRO A 167 114.77 -26.99 REMARK 500 ALA A 173 35.07 -70.28 REMARK 500 ALA A 174 -26.32 -147.95 REMARK 500 THR A 188 -57.68 -13.77 REMARK 500 PHE A 245 -71.38 -100.55 REMARK 500 THR A 260 -38.96 -32.62 REMARK 500 ARG B 25 -14.24 -140.05 REMARK 500 ALA B 29 38.61 -65.61 REMARK 500 GLN B 31 -169.92 -127.67 REMARK 500 LEU B 81 -15.31 -43.51 REMARK 500 ASN B 109 -38.73 -39.79 REMARK 500 LEU B 154 -61.26 -95.06 REMARK 500 LEU B 191 74.88 -165.10 REMARK 500 PRO B 192 -55.92 -23.75 REMARK 500 ARG B 277 146.19 -177.37 REMARK 500 GLN B 321 32.88 -98.50 REMARK 500 ALA C 40 -178.34 -66.59 REMARK 500 GLU C 94 -83.68 -55.59 REMARK 500 LYS C 97 -9.59 -55.65 REMARK 500 ALA C 110 1.14 -54.94 REMARK 500 ALA C 117 48.67 -103.83 REMARK 500 ASN C 121 40.92 -149.29 REMARK 500 THR C 127 -140.78 -122.68 REMARK 500 ASP C 131 71.01 -106.99 REMARK 500 SER C 137 160.06 176.82 REMARK 500 LEU C 154 -79.52 -86.91 REMARK 500 ASP C 157 91.87 -57.52 REMARK 500 ARG C 183 43.79 -64.35 REMARK 500 ASN C 186 -134.29 -72.37 REMARK 500 LEU C 187 -1.65 -178.74 REMARK 500 GLU C 189 -80.72 -65.74 REMARK 500 LEU C 191 66.18 -156.88 REMARK 500 PRO C 192 108.36 -59.31 REMARK 500 ALA C 236 -61.32 -25.99 REMARK 500 PHE C 245 -72.11 -86.04 REMARK 500 ALA C 313 -9.44 -56.35 REMARK 500 PHE C 318 46.77 -156.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LPA A 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LPA B 338 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1X2G RELATED DB: PDB REMARK 900 THE SAME PROTEIN DBREF 1X2H A 1 337 UNP P32099 LPLA_ECOLI 1 337 DBREF 1X2H B 1 337 UNP P32099 LPLA_ECOLI 1 337 DBREF 1X2H C 1 337 UNP P32099 LPLA_ECOLI 1 337 SEQADV 1X2H MSE A 27 UNP P32099 MET 27 MODIFIED RESIDUE SEQADV 1X2H MSE A 60 UNP P32099 MET 60 MODIFIED RESIDUE SEQADV 1X2H MSE A 89 UNP P32099 MET 89 MODIFIED RESIDUE SEQADV 1X2H MSE A 306 UNP P32099 MET 306 MODIFIED RESIDUE SEQADV 1X2H MSE A 332 UNP P32099 MET 332 MODIFIED RESIDUE SEQADV 1X2H MSE B 27 UNP P32099 MET 27 MODIFIED RESIDUE SEQADV 1X2H MSE B 60 UNP P32099 MET 60 MODIFIED RESIDUE SEQADV 1X2H MSE B 89 UNP P32099 MET 89 MODIFIED RESIDUE SEQADV 1X2H MSE B 306 UNP P32099 MET 306 MODIFIED RESIDUE SEQADV 1X2H MSE B 332 UNP P32099 MET 332 MODIFIED RESIDUE SEQADV 1X2H MSE C 27 UNP P32099 MET 27 MODIFIED RESIDUE SEQADV 1X2H MSE C 60 UNP P32099 MET 60 MODIFIED RESIDUE SEQADV 1X2H MSE C 89 UNP P32099 MET 89 MODIFIED RESIDUE SEQADV 1X2H MSE C 306 UNP P32099 MET 306 MODIFIED RESIDUE SEQADV 1X2H MSE C 332 UNP P32099 MET 332 MODIFIED RESIDUE SEQRES 1 A 337 SER THR LEU ARG LEU LEU ILE SER ASP SER TYR ASP PRO SEQRES 2 A 337 TRP PHE ASN LEU ALA VAL GLU GLU CYS ILE PHE ARG GLN SEQRES 3 A 337 MSE PRO ALA THR GLN ARG VAL LEU PHE LEU TRP ARG ASN SEQRES 4 A 337 ALA ASP THR VAL VAL ILE GLY ARG ALA GLN ASN PRO TRP SEQRES 5 A 337 LYS GLU CYS ASN THR ARG ARG MSE GLU GLU ASP ASN VAL SEQRES 6 A 337 ARG LEU ALA ARG ARG SER SER GLY GLY GLY ALA VAL PHE SEQRES 7 A 337 HIS ASP LEU GLY ASN THR CYS PHE THR PHE MSE ALA GLY SEQRES 8 A 337 LYS PRO GLU TYR ASP LYS THR ILE SER THR SER ILE VAL SEQRES 9 A 337 LEU ASN ALA LEU ASN ALA LEU GLY VAL SER ALA GLU ALA SEQRES 10 A 337 SER GLY ARG ASN ASP LEU VAL VAL LYS THR VAL GLU GLY SEQRES 11 A 337 ASP ARG LYS VAL SER GLY SER ALA TYR ARG GLU THR LYS SEQRES 12 A 337 ASP ARG GLY PHE HIS HIS GLY THR LEU LEU LEU ASN ALA SEQRES 13 A 337 ASP LEU SER ARG LEU ALA ASN TYR LEU ASN PRO ASP LYS SEQRES 14 A 337 LYS LYS LEU ALA ALA LYS GLY ILE THR SER VAL ARG SER SEQRES 15 A 337 ARG VAL THR ASN LEU THR GLU LEU LEU PRO GLY ILE THR SEQRES 16 A 337 HIS GLU GLN VAL CYS GLU ALA ILE THR GLU ALA PHE PHE SEQRES 17 A 337 ALA HIS TYR GLY GLU ARG VAL GLU ALA GLU ILE ILE SER SEQRES 18 A 337 PRO ASN LYS THR PRO ASP LEU PRO ASN PHE ALA GLU THR SEQRES 19 A 337 PHE ALA ARG GLN SER SER TRP GLU TRP ASN PHE GLY GLN SEQRES 20 A 337 ALA PRO ALA PHE SER HIS LEU LEU ASP GLU ARG PHE THR SEQRES 21 A 337 TRP GLY GLY VAL GLU LEU HIS PHE ASP VAL GLU LYS GLY SEQRES 22 A 337 HIS ILE THR ARG ALA GLN VAL PHE THR ASP SER LEU ASN SEQRES 23 A 337 PRO ALA PRO LEU GLU ALA LEU ALA GLY ARG LEU GLN GLY SEQRES 24 A 337 CYS LEU TYR ARG ALA ASP MSE LEU GLN GLN GLU CYS GLU SEQRES 25 A 337 ALA LEU LEU VAL ASP PHE PRO GLU GLN GLU LYS GLU LEU SEQRES 26 A 337 ARG GLU LEU SER ALA TRP MSE ALA GLY ALA VAL ARG SEQRES 1 B 337 SER THR LEU ARG LEU LEU ILE SER ASP SER TYR ASP PRO SEQRES 2 B 337 TRP PHE ASN LEU ALA VAL GLU GLU CYS ILE PHE ARG GLN SEQRES 3 B 337 MSE PRO ALA THR GLN ARG VAL LEU PHE LEU TRP ARG ASN SEQRES 4 B 337 ALA ASP THR VAL VAL ILE GLY ARG ALA GLN ASN PRO TRP SEQRES 5 B 337 LYS GLU CYS ASN THR ARG ARG MSE GLU GLU ASP ASN VAL SEQRES 6 B 337 ARG LEU ALA ARG ARG SER SER GLY GLY GLY ALA VAL PHE SEQRES 7 B 337 HIS ASP LEU GLY ASN THR CYS PHE THR PHE MSE ALA GLY SEQRES 8 B 337 LYS PRO GLU TYR ASP LYS THR ILE SER THR SER ILE VAL SEQRES 9 B 337 LEU ASN ALA LEU ASN ALA LEU GLY VAL SER ALA GLU ALA SEQRES 10 B 337 SER GLY ARG ASN ASP LEU VAL VAL LYS THR VAL GLU GLY SEQRES 11 B 337 ASP ARG LYS VAL SER GLY SER ALA TYR ARG GLU THR LYS SEQRES 12 B 337 ASP ARG GLY PHE HIS HIS GLY THR LEU LEU LEU ASN ALA SEQRES 13 B 337 ASP LEU SER ARG LEU ALA ASN TYR LEU ASN PRO ASP LYS SEQRES 14 B 337 LYS LYS LEU ALA ALA LYS GLY ILE THR SER VAL ARG SER SEQRES 15 B 337 ARG VAL THR ASN LEU THR GLU LEU LEU PRO GLY ILE THR SEQRES 16 B 337 HIS GLU GLN VAL CYS GLU ALA ILE THR GLU ALA PHE PHE SEQRES 17 B 337 ALA HIS TYR GLY GLU ARG VAL GLU ALA GLU ILE ILE SER SEQRES 18 B 337 PRO ASN LYS THR PRO ASP LEU PRO ASN PHE ALA GLU THR SEQRES 19 B 337 PHE ALA ARG GLN SER SER TRP GLU TRP ASN PHE GLY GLN SEQRES 20 B 337 ALA PRO ALA PHE SER HIS LEU LEU ASP GLU ARG PHE THR SEQRES 21 B 337 TRP GLY GLY VAL GLU LEU HIS PHE ASP VAL GLU LYS GLY SEQRES 22 B 337 HIS ILE THR ARG ALA GLN VAL PHE THR ASP SER LEU ASN SEQRES 23 B 337 PRO ALA PRO LEU GLU ALA LEU ALA GLY ARG LEU GLN GLY SEQRES 24 B 337 CYS LEU TYR ARG ALA ASP MSE LEU GLN GLN GLU CYS GLU SEQRES 25 B 337 ALA LEU LEU VAL ASP PHE PRO GLU GLN GLU LYS GLU LEU SEQRES 26 B 337 ARG GLU LEU SER ALA TRP MSE ALA GLY ALA VAL ARG SEQRES 1 C 337 SER THR LEU ARG LEU LEU ILE SER ASP SER TYR ASP PRO SEQRES 2 C 337 TRP PHE ASN LEU ALA VAL GLU GLU CYS ILE PHE ARG GLN SEQRES 3 C 337 MSE PRO ALA THR GLN ARG VAL LEU PHE LEU TRP ARG ASN SEQRES 4 C 337 ALA ASP THR VAL VAL ILE GLY ARG ALA GLN ASN PRO TRP SEQRES 5 C 337 LYS GLU CYS ASN THR ARG ARG MSE GLU GLU ASP ASN VAL SEQRES 6 C 337 ARG LEU ALA ARG ARG SER SER GLY GLY GLY ALA VAL PHE SEQRES 7 C 337 HIS ASP LEU GLY ASN THR CYS PHE THR PHE MSE ALA GLY SEQRES 8 C 337 LYS PRO GLU TYR ASP LYS THR ILE SER THR SER ILE VAL SEQRES 9 C 337 LEU ASN ALA LEU ASN ALA LEU GLY VAL SER ALA GLU ALA SEQRES 10 C 337 SER GLY ARG ASN ASP LEU VAL VAL LYS THR VAL GLU GLY SEQRES 11 C 337 ASP ARG LYS VAL SER GLY SER ALA TYR ARG GLU THR LYS SEQRES 12 C 337 ASP ARG GLY PHE HIS HIS GLY THR LEU LEU LEU ASN ALA SEQRES 13 C 337 ASP LEU SER ARG LEU ALA ASN TYR LEU ASN PRO ASP LYS SEQRES 14 C 337 LYS LYS LEU ALA ALA LYS GLY ILE THR SER VAL ARG SER SEQRES 15 C 337 ARG VAL THR ASN LEU THR GLU LEU LEU PRO GLY ILE THR SEQRES 16 C 337 HIS GLU GLN VAL CYS GLU ALA ILE THR GLU ALA PHE PHE SEQRES 17 C 337 ALA HIS TYR GLY GLU ARG VAL GLU ALA GLU ILE ILE SER SEQRES 18 C 337 PRO ASN LYS THR PRO ASP LEU PRO ASN PHE ALA GLU THR SEQRES 19 C 337 PHE ALA ARG GLN SER SER TRP GLU TRP ASN PHE GLY GLN SEQRES 20 C 337 ALA PRO ALA PHE SER HIS LEU LEU ASP GLU ARG PHE THR SEQRES 21 C 337 TRP GLY GLY VAL GLU LEU HIS PHE ASP VAL GLU LYS GLY SEQRES 22 C 337 HIS ILE THR ARG ALA GLN VAL PHE THR ASP SER LEU ASN SEQRES 23 C 337 PRO ALA PRO LEU GLU ALA LEU ALA GLY ARG LEU GLN GLY SEQRES 24 C 337 CYS LEU TYR ARG ALA ASP MSE LEU GLN GLN GLU CYS GLU SEQRES 25 C 337 ALA LEU LEU VAL ASP PHE PRO GLU GLN GLU LYS GLU LEU SEQRES 26 C 337 ARG GLU LEU SER ALA TRP MSE ALA GLY ALA VAL ARG MODRES 1X2H MSE A 27 MET SELENOMETHIONINE MODRES 1X2H MSE A 60 MET SELENOMETHIONINE MODRES 1X2H MSE A 89 MET SELENOMETHIONINE MODRES 1X2H MSE A 306 MET SELENOMETHIONINE MODRES 1X2H MSE A 332 MET SELENOMETHIONINE MODRES 1X2H MSE B 27 MET SELENOMETHIONINE MODRES 1X2H MSE B 60 MET SELENOMETHIONINE MODRES 1X2H MSE B 89 MET SELENOMETHIONINE MODRES 1X2H MSE B 306 MET SELENOMETHIONINE MODRES 1X2H MSE B 332 MET SELENOMETHIONINE MODRES 1X2H MSE C 27 MET SELENOMETHIONINE MODRES 1X2H MSE C 60 MET SELENOMETHIONINE MODRES 1X2H MSE C 89 MET SELENOMETHIONINE MODRES 1X2H MSE C 306 MET SELENOMETHIONINE MODRES 1X2H MSE C 332 MET SELENOMETHIONINE HET MSE A 27 8 HET MSE A 60 8 HET MSE A 89 8 HET MSE A 306 8 HET MSE A 332 8 HET MSE B 27 8 HET MSE B 60 8 HET MSE B 89 8 HET MSE B 306 8 HET MSE B 332 8 HET MSE C 27 8 HET MSE C 60 8 HET MSE C 89 8 HET MSE C 306 8 HET MSE C 332 8 HET LPA A 338 12 HET LPA B 338 12 HETNAM MSE SELENOMETHIONINE HETNAM LPA LIPOIC ACID HETSYN LPA 5-[(3R)-1,2-DITHIOLAN-3-YL]PENTANOIC ACID FORMUL 1 MSE 15(C5 H11 N O2 SE) FORMUL 4 LPA 2(C8 H14 O2 S2) FORMUL 6 HOH *22(H2 O) HELIX 1 1 ASP A 12 GLN A 26 1 15 HELIX 2 2 ASN A 50 CYS A 55 1 6 HELIX 3 3 ASN A 56 ASP A 63 1 8 HELIX 4 4 ASP A 96 ALA A 110 1 15 HELIX 5 5 SER A 159 LEU A 165 1 7 HELIX 6 6 ASP A 168 ALA A 173 1 6 HELIX 7 7 THR A 195 GLY A 212 1 18 HELIX 8 8 ASN A 230 SER A 240 1 11 HELIX 9 9 SER A 240 PHE A 245 1 6 HELIX 10 10 PRO A 287 ARG A 296 1 10 HELIX 11 11 ARG A 303 LEU A 314 1 12 HELIX 12 12 LEU A 315 GLU A 320 5 6 HELIX 13 13 GLN A 321 VAL A 336 1 16 HELIX 14 14 ASP B 12 GLN B 26 1 15 HELIX 15 15 ASN B 50 CYS B 55 1 6 HELIX 16 16 ASN B 56 ASN B 64 1 9 HELIX 17 17 ASP B 96 LEU B 111 1 16 HELIX 18 18 SER B 159 TYR B 164 5 6 HELIX 19 19 ASP B 168 ALA B 174 1 7 HELIX 20 20 LEU B 187 LEU B 191 5 5 HELIX 21 21 THR B 195 TYR B 211 1 17 HELIX 22 22 ASN B 230 SER B 239 1 10 HELIX 23 23 SER B 240 PHE B 245 1 6 HELIX 24 24 PRO B 287 ARG B 296 1 10 HELIX 25 25 ARG B 303 ALA B 313 1 11 HELIX 26 26 LEU B 314 GLU B 320 5 7 HELIX 27 27 GLN B 321 ARG B 337 1 17 HELIX 28 28 ASP C 12 GLN C 26 1 15 HELIX 29 29 ASN C 50 CYS C 55 1 6 HELIX 30 30 ASN C 56 ASP C 63 1 8 HELIX 31 31 ASP C 96 ALA C 110 1 15 HELIX 32 32 SER C 159 LEU C 165 5 7 HELIX 33 33 THR C 195 GLY C 212 1 18 HELIX 34 34 ASN C 230 SER C 240 1 11 HELIX 35 35 SER C 240 PHE C 245 1 6 HELIX 36 36 PRO C 287 ARG C 296 1 10 HELIX 37 37 ARG C 303 ALA C 313 1 11 HELIX 38 38 LEU C 314 GLU C 320 5 7 HELIX 39 39 GLN C 321 VAL C 336 1 16 SHEET 1 A 8 ALA A 115 ALA A 117 0 SHEET 2 A 8 LEU A 123 VAL A 125 -1 O VAL A 124 N GLU A 116 SHEET 3 A 8 ARG A 132 GLU A 141 -1 O VAL A 134 N LEU A 123 SHEET 4 A 8 ARG A 145 LEU A 153 -1 O LEU A 153 N VAL A 134 SHEET 5 A 8 ASN A 83 GLY A 91 -1 N ALA A 90 O GLY A 146 SHEET 6 A 8 ARG A 32 TRP A 37 -1 N VAL A 33 O MSE A 89 SHEET 7 A 8 LEU A 3 SER A 8 1 N LEU A 6 O LEU A 34 SHEET 8 A 8 ALA A 217 ILE A 220 1 O GLU A 218 N ILE A 7 SHEET 1 B 3 ARG A 66 ARG A 69 0 SHEET 2 B 3 THR A 42 ILE A 45 1 N VAL A 43 O ARG A 66 SHEET 3 B 3 VAL A 77 HIS A 79 -1 O VAL A 77 N VAL A 44 SHEET 1 C 3 HIS A 253 PHE A 259 0 SHEET 2 C 3 GLY A 262 GLU A 271 -1 O LEU A 266 N LEU A 255 SHEET 3 C 3 HIS A 274 THR A 282 -1 O GLN A 279 N HIS A 267 SHEET 1 D 7 LEU B 123 THR B 127 0 SHEET 2 D 7 GLY B 130 GLU B 141 -1 O GLY B 130 N THR B 127 SHEET 3 D 7 ARG B 145 LEU B 153 -1 O PHE B 147 N ARG B 140 SHEET 4 D 7 ASN B 83 GLY B 91 -1 N PHE B 88 O HIS B 148 SHEET 5 D 7 ARG B 32 TRP B 37 -1 N VAL B 33 O MSE B 89 SHEET 6 D 7 LEU B 3 SER B 8 1 N ARG B 4 O ARG B 32 SHEET 7 D 7 GLU B 218 ILE B 220 1 O GLU B 218 N LEU B 5 SHEET 1 E 3 ARG B 66 ARG B 69 0 SHEET 2 E 3 THR B 42 ILE B 45 1 N ILE B 45 O ALA B 68 SHEET 3 E 3 VAL B 77 HIS B 79 -1 O VAL B 77 N VAL B 44 SHEET 1 F 3 HIS B 253 PHE B 259 0 SHEET 2 F 3 GLY B 262 GLU B 271 -1 O LEU B 266 N LEU B 255 SHEET 3 F 3 HIS B 274 THR B 282 -1 O GLN B 279 N HIS B 267 SHEET 1 G 7 LEU C 123 VAL C 125 0 SHEET 2 G 7 ARG C 132 GLU C 141 -1 O SER C 135 N LEU C 123 SHEET 3 G 7 ARG C 145 LEU C 153 -1 O PHE C 147 N ARG C 140 SHEET 4 G 7 ASN C 83 GLY C 91 -1 N ALA C 90 O GLY C 146 SHEET 5 G 7 ARG C 32 TRP C 37 -1 N PHE C 35 O THR C 87 SHEET 6 G 7 LEU C 3 SER C 8 1 N LEU C 6 O LEU C 36 SHEET 7 G 7 GLU C 218 ILE C 220 1 O GLU C 218 N LEU C 5 SHEET 1 H 3 ARG C 66 ARG C 69 0 SHEET 2 H 3 THR C 42 ILE C 45 1 N VAL C 43 O ARG C 66 SHEET 3 H 3 VAL C 77 HIS C 79 -1 O VAL C 77 N VAL C 44 SHEET 1 I 3 HIS C 253 PHE C 259 0 SHEET 2 I 3 GLY C 262 GLU C 271 -1 O LEU C 266 N LEU C 255 SHEET 3 I 3 HIS C 274 THR C 282 -1 O GLN C 279 N HIS C 267 LINK C GLN A 26 N MSE A 27 1555 1555 1.33 LINK C MSE A 27 N PRO A 28 1555 1555 1.34 LINK C ARG A 59 N MSE A 60 1555 1555 1.33 LINK C MSE A 60 N GLU A 61 1555 1555 1.34 LINK C PHE A 88 N MSE A 89 1555 1555 1.32 LINK C MSE A 89 N ALA A 90 1555 1555 1.33 LINK C ASP A 305 N MSE A 306 1555 1555 1.34 LINK C MSE A 306 N LEU A 307 1555 1555 1.33 LINK C TRP A 331 N MSE A 332 1555 1555 1.33 LINK C MSE A 332 N ALA A 333 1555 1555 1.33 LINK C GLN B 26 N MSE B 27 1555 1555 1.32 LINK C MSE B 27 N PRO B 28 1555 1555 1.34 LINK C ARG B 59 N MSE B 60 1555 1555 1.34 LINK C MSE B 60 N GLU B 61 1555 1555 1.32 LINK C PHE B 88 N MSE B 89 1555 1555 1.31 LINK C MSE B 89 N ALA B 90 1555 1555 1.33 LINK C ASP B 305 N MSE B 306 1555 1555 1.33 LINK C MSE B 306 N LEU B 307 1555 1555 1.32 LINK C TRP B 331 N MSE B 332 1555 1555 1.34 LINK C MSE B 332 N ALA B 333 1555 1555 1.33 LINK C GLN C 26 N MSE C 27 1555 1555 1.32 LINK C MSE C 27 N PRO C 28 1555 1555 1.34 LINK C ARG C 59 N MSE C 60 1555 1555 1.34 LINK C MSE C 60 N GLU C 61 1555 1555 1.32 LINK C PHE C 88 N MSE C 89 1555 1555 1.32 LINK C MSE C 89 N ALA C 90 1555 1555 1.33 LINK C ASP C 305 N MSE C 306 1555 1555 1.32 LINK C MSE C 306 N LEU C 307 1555 1555 1.33 LINK C TRP C 331 N MSE C 332 1555 1555 1.32 LINK C MSE C 332 N ALA C 333 1555 1555 1.34 CISPEP 1 LYS A 92 PRO A 93 0 6.55 CISPEP 2 LYS B 92 PRO B 93 0 -6.47 CISPEP 3 LYS C 92 PRO C 93 0 11.10 SITE 1 AC1 6 GLU A 21 PHE A 24 SER A 72 ARG A 140 SITE 2 AC1 6 PHE A 147 HIS A 149 SITE 1 AC2 6 LEU B 17 GLU B 21 PHE B 24 ALA B 138 SITE 2 AC2 6 ARG B 140 HIS B 149 CRYST1 83.200 111.600 289.600 90.00 90.00 90.00 C 2 2 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012019 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008961 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003453 0.00000